Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction.
about
Did clinical trials in which erythropoietin failed to reduce acute myocardial infarct size miss a narrow therapeutic window?The effect of erythropoietin on normal and neoplastic cells.Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.Promises and pitfalls in erythopoietin-mediated tissue protection: are nonerythropoietic derivatives a way forward?High-dose erythropoietin in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized controlled trials.Ischemia/reperfusion injury and cardioprotective mechanisms: Role of mitochondria and reactive oxygen speciesFunctional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trialIntravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.Baseline Hemoglobin Levels Associated with One-Year Mortality in ST-Segment Elevation Myocardial Infarction PatientsHematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond.New strategies for the management of no-reflow after primary percutaneous coronary intervention.Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.Effect of erythropoiesis-stimulating agents in acute ST-segment elevation myocardial infarction: a systematic review.Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy.The nephroprotective properties of recombinant human erythropoietin in kidney transplantation: experimental facts and clinical proofs.Safety of off-label erythropoiesis stimulating agents in critically ill patients: a meta-analysis.High-dose erythropoietin for tissue protection.Perioperative administration of high-dose recombinant human erythropoietin for delayed graft function prevention in kidney transplantation: a meta-analysis.Harms of off-label erythropoiesis-stimulating agents for critically ill people.Development of an in vitro model of myotube ischemia.A single dose of erythropoietin in ST-elevation myocardial infarction.
P2860
Q31056941-9C25B0E2-F888-48CF-BC7A-21A07679DB6DQ34291437-B66FE6C0-C39A-44F8-8E63-35DD64C8B654Q34479931-2A2CB27E-E8EA-480B-A942-720D52940980Q34504572-AB0614DF-B0BB-4E20-B74A-EA32203A8F73Q35008662-C65429F0-F018-4DAC-A37E-15570219F474Q35113412-1EB16977-8E8B-4E9C-A5BC-CCB1C791C351Q35217404-3C4DA047-2C55-4B16-90FD-5A9AD677CE99Q36199501-E7ACC4AB-A210-4DD0-BD77-317240E4B82DQ36364317-E503A0E5-4C6A-4A54-B4B8-DEE715DCAA0CQ37448627-180F43D0-66A3-4452-90FB-297F23960B46Q37871920-F27ED496-2CCD-4B29-9044-FE3E4AC2AFFAQ37880139-EFB9FD24-7960-4CB1-A235-D7F3E6AF4014Q37883005-32000FFD-FF1F-400A-84ED-8B73052776BEQ37956569-3AFDE6E0-0B54-4794-B639-1BA376B5260CQ38010782-D39125C0-C7E1-432A-A5DD-E35F90346808Q38051422-90C14D5E-18FA-4B0A-AB4D-E915797BD82FQ38127584-FEC71588-B3D5-48E5-8FBE-EF9423F3F7BBQ38262836-089406F5-64E8-480E-9B98-F8F0B58E66CEQ38291225-CD87ADD5-8FE1-4786-9186-4A71A3C09833Q38608377-96300273-6F8A-437E-9027-79E2C93551B1Q39537577-799DD320-8BFB-455C-8A9C-307E2164A708Q42923034-D7690563-13C0-437D-973A-8871715B51FE
P2860
Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Erythropoietin to augment myoc ...... n acute myocardial infarction.
@en
Erythropoietin to augment myoc ...... n acute myocardial infarction.
@nl
type
label
Erythropoietin to augment myoc ...... n acute myocardial infarction.
@en
Erythropoietin to augment myoc ...... n acute myocardial infarction.
@nl
prefLabel
Erythropoietin to augment myoc ...... n acute myocardial infarction.
@en
Erythropoietin to augment myoc ...... n acute myocardial infarction.
@nl
P2093
P921
P1476
Erythropoietin to augment myoc ...... n acute myocardial infarction.
@en
P2093
Azan S Binbrek
Burton E Sobel
Jamal Assaqqaf
Najib Al Khaja
Nayan S Rao
P304
P356
10.1016/J.AMJCARD.2009.05.050
P407
P577
2009-10-01T00:00:00Z